Efficacy and Safety of Platelet-Rich Plasma for Patients With Meniscal Injury: A Systematic Review and Meta-analysis of Randomized Controlled Trials
Orthopaedic Journal of Sports Medicine · 2025-10 · 13 (10)
DOI: 10.1177/23259671251371233 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Orthopaedic Journal of Sports Medicine, online erschienen am 03.10.2025. Verfasst von Jianshui Liang und 4 weiteren Autor:innen. Beteiligte Einrichtung: The First Department of Spine, Maoming Hospital affiliated to Guangzhou University of Chinese Medicine, Maoming, China. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Platelet-rich plasma (PRP) is widely used to promote healing and improve function in various musculoskeletal injuries. However, the efficacy and safety of PRP for meniscal injury remain unclear.
Purpose
To evaluate the effects of PRP in patients with meniscal injury. Study Design: Systematic review; Level of evidence, 2.
Methods
A comprehensive search was conducted in PubMed, Embase, Cochrane Library, Web of Science, Wanfang, and CNKI databases. Randomized controlled trials comparing PRP with placebo or no additional treatment in adult patients with meniscal injury were included. Outcome measures included the visual analog scale for knee pain, Lysholm score, Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), Knee injury and Osteoarthritis Outcome Score (KOOS), treatment failure, and complications. Data were pooled using a random-effects model by incorporating the influence of heterogeneity.
Results
This meta-analysis included 18 randomized controlled trials involving a total of 1143 patients. The mean follow-up duration ranged from 3 to 12 months. PRP significantly reduced knee pain (mean difference [MD], −0.73; 95% CI, −0.91 to −0.55) and improved knee function, as indicated by higher Lysholm scores (MD, 6.77; 95% CI, 5.35 to 8.20) and KOOS (MD, 4.34; 95% CI, 1.35 to 7.32), and lower WOMAC scores (MD, –5.33; 95% CI, −8.10 to −2.56). Subgroup analyses suggested similar results in patients with and without concurrent knee osteoarthritis, with single and multiple PRP injection, and with follow-up duration of
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The First Department of Spine, Maoming Hospital affiliated to Guangzhou University of Chinese Medicine, Maoming, China.
- The Department of Orthopedics, Maoming Hospital affiliated to Guangzhou University of Chinese Medicine, Maoming, China.
- The First Department of Joint, Hospital affiliated to Guangzhou University of Chinese Medicine, Maoming, China.
- The Second Department of Joint, Hospital affiliated to Guangzhou University of Chinese Medicine, Maoming, China.
Zitieren
APA
Liang, J., Tu, M., Li, H., Chen, W., & Wang, C. (2025). Efficacy and Safety of Platelet-Rich Plasma for Patients With Meniscal Injury: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Orthopaedic Journal of Sports Medicine, 13(10). https://doi.org/10.1177/23259671251371233
Vancouver
Liang J, Tu M, Li H, Chen W, Wang C. Efficacy and Safety of Platelet-Rich Plasma for Patients With Meniscal Injury: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Orthopaedic Journal of Sports Medicine. 2025;13(10). doi:10.1177/23259671251371233
BibTeX
@article{Liang2025,
author = {Liang, Jianshui and Tu, Mingzhong and Li, Haitao and Chen, Wangzhu and Wang, Chunjiang},
title = {Efficacy and Safety of Platelet-Rich Plasma for Patients With Meniscal Injury: A Systematic Review and Meta-analysis of Randomized Controlled Trials},
journal = {Orthopaedic Journal of Sports Medicine},
year = {2025},
volume = {13},
number = {10},
doi = {10.1177/23259671251371233}
}
EUVIMED